title: 5th International Workshop on Chronic Lymphocytic Leukemia.
abstract: In the past few years important advances have been made in our understanding of the biology and natural history of CLL; also, new strategies and agents offer promise in the treatment of this form of leukemia. Now, patients can be treated on a more rationale basis and with real prospects for a sustained control of their disease, and improved quality of life. Hopefully, progresses in CLL will continue to accumulate in the coming years.
authors.affiliation: Postgraduate School of Hematology, Farreras Valenti, Hospital Clínic, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Montserrat
authors.forename: J L
authors.initials: JL
authors.lastname: Binet
authors.forename: D
authors.initials: D
authors.lastname: Catovsky
authors.forename: G
authors.initials: G
authors.lastname: Dighiero
authors.forename: R P
authors.initials: RP
authors.lastname: Gale
authors.forename: K R
authors.initials: KR
authors.lastname: Rai
authors.forename: C
authors.initials: C
authors.lastname: Rozman
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D015322:Gene Rearrangement, B-Lymphocyte; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D051379:Mice; D011379:Prognosis
chemical_list: D006133:Growth Substances